tiprankstipranks
Trending News
More News >
Lee's Pharmaceutical Holdings Limited (HK:0950)
:0950
Hong Kong Market

Lee's Pharmaceutical Holdings Limited (0950) Financial Statements

Compare
0 Followers

Lee's Pharmaceutical Holdings Limited Financial Overview

Lee's Pharmaceutical Holdings Limited's market cap is currently HK$889.14M. The company's EPS TTM is HK$; its P/E ratio is 9.55; and it has a dividend yield of 3.31%. Lee's Pharmaceutical Holdings Limited is scheduled to report earnings on May 28, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total RevenueHK$ 1.40BHK$ 1.05BHK$ 1.23BHK$ 1.27BHK$ 1.22B
Gross ProfitHK$ 753.36MHK$ 551.31MHK$ 770.75MHK$ 806.28MHK$ 781.07M
Operating IncomeHK$ 113.14MHK$ 43.55MHK$ 123.02MHK$ -694.00KHK$ 151.92M
EBITDAHK$ 260.87MHK$ 193.05MHK$ 229.06MHK$ 2.13BHK$ 279.43M
Net IncomeHK$ 93.10MHK$ 16.70MHK$ 51.28MHK$ 1.99BHK$ 78.53M
Balance Sheet
Cash & Short-Term InvestmentsHK$ 216.84MHK$ 171.00MHK$ 189.30MHK$ 277.53MHK$ 414.54M
Total AssetsHK$ 2.62BHK$ 2.89BHK$ 2.78BHK$ 3.64BHK$ 3.25B
Total DebtHK$ 227.30MHK$ 204.14MHK$ 163.49MHK$ 267.14MHK$ 156.71M
Net DebtHK$ 10.45MHK$ 33.14MHK$ -25.81MHK$ -10.39MHK$ -257.83M
Total LiabilitiesHK$ 1.07BHK$ 930.07MHK$ 939.50MHK$ 1.25BHK$ 1.14B
Stockholders' EquityHK$ 1.65BHK$ 2.04BHK$ 1.92BHK$ 2.46BHK$ 2.15B
Cash Flow
Free Cash FlowHK$ 34.45MHK$ -45.89MHK$ 69.81MHK$ -160.04MHK$ -139.23M
Operating Cash FlowHK$ 242.01MHK$ 110.08MHK$ 283.63MHK$ 210.68MHK$ 218.91M
Investing Cash FlowHK$ -192.36MHK$ -145.22MHK$ -256.05MHK$ -370.28MHK$ -523.74M
Financing Cash FlowHK$ -1.96MHK$ 13.44MHK$ -128.60MHK$ 60.97MHK$ -9.80M
Currency in HKD

Lee's Pharmaceutical Holdings Limited Earnings and Revenue History

Lee's Pharmaceutical Holdings Limited Debt to Assets

Lee's Pharmaceutical Holdings Limited Cash Flow

Lee's Pharmaceutical Holdings Limited Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis